Assets Endring Dato
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Genmab DKK 35.24B 3.26B 2023-09
Geron USD 394.08M 18.94M 2023-12
Gilead Sciences USD 62.13B 248M 2023-12
Pfizer USD 215.02B 5.15B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Xencor USD 952.69M 174.26M 2023-12



MacroGenics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.